By Tony Fong

NEW YORK (GenomeWeb News) – Diagnostic companies developing biomarker-based tests usually work with patient samples from subjects who already have a disease for comparison with samples taken from healthy subjects.

But leveraging a biobank that it has licensed from University College London, UK firm Abcodia is betting that samples that allow researchers to track changes in patients going back years to before the onset of disease and through the progression of disease can provide new methods of disease detection.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Oct
11
Sponsored by
ArcherDX

This webinar will discuss a validation study for a next-generation sequencing (NGS) assay for hematological malignancies (e.g., acute myeloid leukemia, acute lymphocytic leukemia, myelodysplastic syndrome, and myeloproliferative neoplasms).